UroGen Pharma

+$0.20 (+1.25%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell UroGen Pharma and other ETFs, options, and stocks.

About URGN

UroGen Pharma Ltd. is a biopharmaceutical company dedicated to building novel solutions that treat specialty cancers and urologic diseases. It has developed RTGel reverse-thermal hydrogel, a proprietary sustained release, hydrogel-based platform technology that has the potential to improve therapeutic profiles of existing drugs.

CEO
Elizabeth Barrett
Employees
187
Headquarters
Princeton, New Jersey
Founded
2004

URGN Key Statistics

Market Cap
360.94M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
83.40K
High Today
$16.47
Low Today
$15.97
Open Price
$16.03
Volume
23.96K
52 Week High
$28.20
52 Week Low
$14.19

URGN Earnings

-$1.86
-$1.24
-$0.62
-$0.00
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Estimated
— per share
Actual
Expected Nov 3, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure